New Delhi, Oct. 8 -- The July-September quarter (Q2FY26) results of Indian healthcare companies are expected to be strong, with revenue likely to grow in the high teens year-on-year (YoY), supported by favourable industry tailwinds, expansion in operational bed capacity, and a steady recovery in international patient inflows, according to brokerage firm Choice Equity Broking.

The brokerage firm highlighted that the ARPOB (average revenue per occupied bed) of healthcare companies under its coverage may see a moderate YoY growth. However, EBITDA may outpace revenue growth across its coverage universe, underscoring continued improvement in operating leverage.

Aggressive capacity expansion and rising global demand are key factors indicating...